0 Beoordelingen
ID

20356

Beschrijving

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one. Visit 5 (Month 12) Study Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Link

https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Trefwoorden

Versies (1)
  1. 21-02-17 21-02-17 -
Geüploaded op

21 februari 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

  • Nieuwste
  • Oudste
  • Populair
  • Nieuwste
    • Nieuwste
    • Oudste
    • Populair

    Geen commentaren

    U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

    Concomitant Medication Visit 5 PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

    Engels

    Concomitant Medication Visit 5 PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

    1 Formulieren  
    Concomitant Medication
    Beschrijving

    Concomitant Medication

    Alias
    UMLS CUI-1
    C2347852
    1. Since visit 2, were any of the non-study medications listed below taken?
    Beschrijving

    Concomitant medication

    Datatype

    boolean

    Alias
    UMLS CUI [1,1]
    C1518384
    UMLS CUI [1,2]
    C0087111
    UMLS CUI [1,3]
    C2347852
    If yes, please indicate which of the following were taken:
    Beschrijving

    If yes, please indicate which

    Datatype

    integer

    Alias
    UMLS CUI [1,1]
    C2347852
    UMLS CUI [1,2]
    C1524063
    ACE Inhibitors
    Beschrijving

    ACE Inhibitors

    Alias
    UMLS CUI-1
    C0003015
    2. Since visit 2, were any ACE inhibitors taken?
    Beschrijving

    ACE Inhibitors currently taken

    Datatype

    boolean

    Alias
    UMLS CUI [1,1]
    C0003015
    UMLS CUI [1,2]
    C1524063
    If yes, please indicate which, and total daily dose:
    Beschrijving

    If yes

    Datatype

    text

    Alias
    UMLS CUI [1,1]
    C0003015
    UMLS CUI [1,2]
    C1524063
    UMLS CUI [2]
    C2348070
    Restricted Concomitant Medication
    Beschrijving

    Restricted Concomitant Medication

    Alias
    UMLS CUI-1
    C2347852
    UMLS CUI-2
    C0443288
    3. Have any restricted medications in the categories defined on the opposite page been taken since visit 2?
    Beschrijving

    Restricted medication taken

    Datatype

    boolean

    Alias
    UMLS CUI [1,1]
    C1518384
    UMLS CUI [1,2]
    C0087111
    UMLS CUI [1,3]
    C2347852
    UMLS CUI [1,4]
    C0443288
    If yes, please indicate which category
    Beschrijving

    if yes

    Datatype

    integer

    Alias
    UMLS CUI [1,1]
    C0683312
    UMLS CUI [1,2]
    C2347852
    UMLS CUI [1,3]
    C0443288
    Terug naar het begin van de pagina

    Similar models

    Concomitant Medication Visit 5 PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

    1 Formulieren
    Name
    Type
    Description | Question | Decode (Coded Value)
    Datatype
    Alias
    Item Group
    Concomitant Medication
    C2347852 (UMLS CUI-1)
    Concomitant medication
    Item
    1. Since visit 2, were any of the non-study medications listed below taken?
    boolean
    C1518384 (UMLS CUI [1,1])
    C0087111 (UMLS CUI [1,2])
    C2347852 (UMLS CUI [1,3])
    Item
    If yes, please indicate which of the following were taken:
    integer
    C2347852 (UMLS CUI [1,1])
    C1524063 (UMLS CUI [1,2])
    If yes, please indicate which
    Code List
    If yes, please indicate which of the following were taken:
    CL Item
    Parental anticoagulants (Short term use)  (1)
    CL Item
    Oral anticoagulants (Short term use) (2)
    CL Item
    Nitrates (oral or topical) (3)
    CL Item
    Estrogen replacement without progesterone (4)
    CL Item
    Estrogen replacement with progesterone (5)
    CL Item
    Digitalis (6)
    CL Item
    Statins (7)
    CL Item
    Fibrates (8)
    CL Item
    Dilitazem/Verapamil (9)
    CL Item
    Other calcium channel blockers (10)
    CL Item
    Alpha-blocker (11)
    CL Item
    Direct vasodilators (12)
    CL Item
    Peripheral sympatholytic (13)
    CL Item
    Central sympatholytic (14)
    CL Item
    Alpha-beta blocker (15)
    CL Item
    Beta-blocker (16)
    CL Item
    Loop-active diuretics (17)
    CL Item
    Diuretics of thiazide type (18)
    CL Item
    Potassium-sparing diuretics (19)
    CL Item
    Insulin (20)
    CL Item
    Oral hypoglycemic agents (21)
    CL Item
    Specific Cox II inhibitors (22)
    Item Group
    ACE Inhibitors
    C0003015 (UMLS CUI-1)
    ACE Inhibitors currently taken
    Item
    2. Since visit 2, were any ACE inhibitors taken?
    boolean
    C0003015 (UMLS CUI [1,1])
    C1524063 (UMLS CUI [1,2])
    If yes
    Item
    If yes, please indicate which, and total daily dose:
    text
    C0003015 (UMLS CUI [1,1])
    C1524063 (UMLS CUI [1,2])
    C2348070 (UMLS CUI [2])
    Item Group
    Restricted Concomitant Medication
    C2347852 (UMLS CUI-1)
    C0443288 (UMLS CUI-2)
    Restricted medication taken
    Item
    3. Have any restricted medications in the categories defined on the opposite page been taken since visit 2?
    boolean
    C1518384 (UMLS CUI [1,1])
    C0087111 (UMLS CUI [1,2])
    C2347852 (UMLS CUI [1,3])
    C0443288 (UMLS CUI [1,4])
    Item
    If yes, please indicate which category
    integer
    C0683312 (UMLS CUI [1,1])
    C2347852 (UMLS CUI [1,2])
    C0443288 (UMLS CUI [1,3])
    if yes
    Code List
    If yes, please indicate which category
    CL Item
    1 (1)
    CL Item
    2 (2)
    CL Item
    3 (3)
    CL Item
    4 (4)
    CL Item
    5 (5)
    CL Item
    6 (6)
    CL Item
    7 (7)
    Terug naar het begin van de pagina 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial